Get alerts
Archived

Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

Posted
August 1, 2024
Closed
November 4, 2024
Award ceiling
$500,000
Program funding
$7,500,000
Expected awards
8
Cost sharing
No
Instrument
Cooperative Agreement
Assistance listing
93.061
Category
Health
Archives
March 9, 2025

Program funding history

Awards made under Assistance Listing 93.061 across FY2024–FY2026, from public federal spending records.

FY2024 obligated
$0
FY2025 obligated
$0
FY2026 (to date) obligated
$0
Awards in window
15

No net new obligations were recorded under this listing in the window shown: downward adjustments to earlier awards offset or exceeded new awards in every year. Awards in window counts awards with at least one recorded transaction in the window, adjustments included.

Top recipients: Creare Llc, Dartmouth-hitchcock Clinic, Northwestern University, Aster Labs, Inc., Tria Bioscience Corp.

Source: USAspending.gov · refreshed September 2026

This opportunity is archived. Applications are no longer accepted. Similar grants are listed below, and the free Tuesday digest carries the next ones like it.

Synopsis

The Centers for Disease Control/Agency for Toxic Substances and Disease Registry (CDC/ATSDR) is seeking investigator-initiated research that will identify and evaluate potential risk factors contributing to Amyotrophic Lateral Sclerosis (ALS), with preferred focus on research proposals that will examine factors related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. Research proposals on preferred topics can be funded under one of three funding options, Funding Option A, Funding Option B, or Funding Option C. Funding Option A is intended to support ALS risk factor research investigations that have an existing, well substantiated evidence base and would benefit from strengthened rigorous evaluation. Funding Option B is intended to support novel ALS risk factor research investigations that may or may not have an existing evidence base, may be supported by limited and insufficient preliminary research, and are exploratory and developmental in nature. Funding Option C is intended to support research and better understanding of ALS risk including prevalence and incidence in communities such as racial and ethnic minority populations (e.g., Black or African American persons, Hispanic or Latino persons, Asian persons) and military veterans.

Who can apply

See Section III. Eligibility Information.

The official record

Grants.gov published the official terms and dates of this opportunity; this page keeps them as they were listed.

View on Grants.gov

Agency contact: Centers for Disease Control and Prevention - ERA · [email protected] · 404-498-2015

Tell me when this program posts again

This round has closed. One email the morning after this program is posted again under a new number (we watch for about two years), and one more about a week before that round closes (the next morning, if it is already closer than that). That is all this sends — it is not a newsletter signup.

Stored once per grant, used only for this watch’s emails; every one carries a one-click unsubscribe. Privacy

Get grants like this every Tuesday — free

One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe any time.

No spam, ever. Privacy

Similar grants

Same-day alerts, matched to you

The free digest is weekly — the same list for everyone. Members get every open federal grant scored to their organization — and an alert the day a real match posts: we read every new posting the day it opens. Free for 30 days, then $29/mo. Card required, cancel any time before day 31.

Not ready for a subscription? A one-time Fit Report — $29 — scores every open federal grant to your organization once, by email within one business day.

See pricing